Grants
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required (RFA-FD-25-001)
Sponsor
U.S. Food and Drug Administration
Award
Due Date
2024 dates: LOI due September 22, 2024; application due October 22, 2024. 2025 dates: LOI due September 21, 2025; application due October 21, 2025.